Cargando…

Drug Induced Interstitial Lung Disease

With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural e...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaiblmair, Martin, Behr, Werner, Haeckel, Thomas, Märkl, Bruno, Foerg, Wolfgang, Berghaus, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415629/
https://www.ncbi.nlm.nih.gov/pubmed/22896776
http://dx.doi.org/10.2174/1874306401206010063
_version_ 1782240373057257472
author Schwaiblmair, Martin
Behr, Werner
Haeckel, Thomas
Märkl, Bruno
Foerg, Wolfgang
Berghaus, Thomas
author_facet Schwaiblmair, Martin
Behr, Werner
Haeckel, Thomas
Märkl, Bruno
Foerg, Wolfgang
Berghaus, Thomas
author_sort Schwaiblmair, Martin
collection PubMed
description With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents. There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease. Other causes of ILD must be excluded. Treatment is avoidance of further exposure and systemic corticosteroids in patients with progressive or disabling disease.
format Online
Article
Text
id pubmed-3415629
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-34156292012-08-15 Drug Induced Interstitial Lung Disease Schwaiblmair, Martin Behr, Werner Haeckel, Thomas Märkl, Bruno Foerg, Wolfgang Berghaus, Thomas Open Respir Med J Article With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents, antibiotics, antiarrhythmic drugs, and immunosuppressive agents. There are no distinct physiologic, radiographic or pathologic patterns of DILD, and the diagnosis is usually made when a patient with interstitial lung disease (ILD) is exposed to a medication known to result in lung disease. Other causes of ILD must be excluded. Treatment is avoidance of further exposure and systemic corticosteroids in patients with progressive or disabling disease. Bentham Open 2012-07-27 /pmc/articles/PMC3415629/ /pubmed/22896776 http://dx.doi.org/10.2174/1874306401206010063 Text en © Schwaiblmair et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Schwaiblmair, Martin
Behr, Werner
Haeckel, Thomas
Märkl, Bruno
Foerg, Wolfgang
Berghaus, Thomas
Drug Induced Interstitial Lung Disease
title Drug Induced Interstitial Lung Disease
title_full Drug Induced Interstitial Lung Disease
title_fullStr Drug Induced Interstitial Lung Disease
title_full_unstemmed Drug Induced Interstitial Lung Disease
title_short Drug Induced Interstitial Lung Disease
title_sort drug induced interstitial lung disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415629/
https://www.ncbi.nlm.nih.gov/pubmed/22896776
http://dx.doi.org/10.2174/1874306401206010063
work_keys_str_mv AT schwaiblmairmartin druginducedinterstitiallungdisease
AT behrwerner druginducedinterstitiallungdisease
AT haeckelthomas druginducedinterstitiallungdisease
AT marklbruno druginducedinterstitiallungdisease
AT foergwolfgang druginducedinterstitiallungdisease
AT berghausthomas druginducedinterstitiallungdisease